Yeole Ujwal, Nagesh Madhusudhan, Shukla Dhaval, R Aravind H, R Prabhuraj A
Department of Surgical oncology, Neurosurgery Services, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
J Neurosci Rural Pract. 2020 Oct;11(4):565-572. doi: 10.1055/s-0040-1714313. Epub 2020 Aug 11.
Despite the technological advancement in imaging, digital subtraction angiography (DSA) remains gold standard imaging modality for spontaneous subarachnoid hemorrhage (SAH). But even after DSA, around 15% of SAH remains elusive for the cause of the bleed. This is an institutional review to solve the mystery, "when is second DSA really indicated?" In a retrospective review from January 2015 to December 2017, we evaluated cases of spontaneous SAH with initial negative DSA with repeat DSA after 6 weeks to rule out vascular abnormality. The spontaneous SAH was confirmed on noncontrast computed tomography (NCCT) and divided into two groups of perimesencephalic SAH (PM-SAH) or nonperimesencephalic SAH (nPM-SAH). The outcome was assessed by a modified Rankin's score (mRS) at 6 months postictus. During the study period, we had 119 cases of initial negative DSA and 98 cases (82.3%) underwent repeat DSA after 6 weeks interval. A total of 53 cases (54.1%) had PM-SAH and 45 cases (45.9%) had nPM-SAH. Repeat DSA after 6 weeks showed no vascular abnormality in 53 cases of PM-SAH and in 2 (4.4%) out of 45 cases of nPM-SAH. At 6 months postictus, all cases of PM-SAH and 93% of nPM-SAH had mRS of 0. We recommend, a repeat DSA is definitely not required in PM-SAH, but it should be done for all cases of nPM-SAH, before labeling them as nonaneurysmal SAH. Although the overall outcome for nonaneurysmal spontaneous SAH is better than aneurysmal SAH, nPM-SAH has poorer eventual outcome compared to PM-SAH.
尽管成像技术取得了进步,但数字减影血管造影(DSA)仍然是自发性蛛网膜下腔出血(SAH)的金标准成像方式。但即使在进行DSA检查后,仍有大约15%的SAH出血原因不明。这是一项机构审查,旨在解开“何时真正需要进行第二次DSA检查?”这一谜团。
在对2015年1月至2017年12月的回顾性研究中,我们评估了初次DSA检查结果为阴性的自发性SAH病例,并在6周后进行重复DSA检查以排除血管异常。通过非增强计算机断层扫描(NCCT)确诊自发性SAH,并将其分为两组,即中脑周围SAH(PM-SAH)或非中脑周围SAH(nPM-SAH)。在发病后6个月时,通过改良Rankin评分(mRS)评估预后。
在研究期间,我们有119例初次DSA检查结果为阴性的病例,其中98例(82.3%)在间隔6周后接受了重复DSA检查。共有53例(54.1%)为PM-SAH,45例(45.9%)为nPM-SAH。6周后的重复DSA检查显示,53例PM-SAH和45例nPM-SAH中的2例(4.4%)未发现血管异常。在发病后6个月时,所有PM-SAH病例和93%的nPM-SAH病例的mRS评分为0。
我们建议,PM-SAH绝对不需要进行重复DSA检查,但对于所有nPM-SAH病例,在将其标记为非动脉瘤性SAH之前,都应进行重复DSA检查。尽管非动脉瘤性自发性SAH的总体预后优于动脉瘤性SAH,但与PM-SAH相比,nPM-SAH的最终预后较差。